iX Biopharma Ltd. (SG:42C) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
iX Biopharma Ltd. has enhanced its Scientific Advisory Board by appointing Dr. Brian Kennedy, a renowned expert in aging and longevity, as a scientific advisor. Dr. Kennedy’s expertise will be pivotal for iX Biopharma’s development and commercialization of innovative healthspan products, including their NAD+ sublingual wafers. This strategic move is expected to advance the company’s research efforts and boost their market presence in the health and wellness sector.
For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.